There are 2934 resources available
5639 - Simultaneous multi-cancer detection and tissue of origin (TOO) localization using targeted bisulfite sequencing of plasma cell-free DNA (cfDNA)
Presenter: Geoffrey Oxnard
Session: Proffered Paper – Translational research
Resources:
Abstract
Slides
Webcast
Results of ESMO survey/collection of data regarding shortage essential medicines in Europe and beyond, along with EIU reports on specific countries
Presenter: Alexandru Eniu
Session: Essential medicines, but not always available
Resources:
Slides
Webcast
Case study: State of play in Pakistan
Presenter: Zeba Aziz
Session: Essential medicines, but not always available
Resources:
Slides
Webcast
WHO perspective: What can be done to mitigate shortages?
Presenter: Nicola Magrini
Session: Essential medicines, but not always available
Resources:
Slides
Webcast
EONS - Welcome by Spanish Oncology Nursing Society (Sociedad Española de Enfermería Oncológica, SEEO)
Presenter: Nuria Domenech
Session: EONS 12: Opening session
Resources:
Slides
Webcast
EONS - Cancer nursing research, closing the gap between science and clinical practice
Presenter: Maria Teresa Moreno-Casbas
Session: EONS 12: Opening session
Resources:
Slides
Webcast
EONS - Leadership, combining research with daily practice
Presenter: Hester Vermeulen
Session: EONS 12: Opening session
Resources:
Slides
Webcast
811 - ENTRATA: Randomized, double-blind, phase 2 study of telaglenastat (tela; CB-839) + everolimus (E) vs. placebo (pbo) + E in patients (pts) with advanced/metastatic renal cell carcinoma (mRCC)
Presenter: Chung-Han Lee
Session: Proffered Paper 1 – Genitourinary tumours, non-prostate
Resources:
Abstract
Slides
Webcast
1056 - Primary 2-year (yr) results of a phase 2, multicenter, randomized, open-label trial of efficacy and safety for talimogene laherparepvec (T-VEC) neoadjuvant (neo) treatment (tx) plus surgery (surg) vs surg in patients (pts) with resectable stage IIIB-IVM1a melanoma
Presenter: Reinhard Dummer
Session: Proffered Paper – Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
2898 - Adjuvant immunotherapy with nivolumab (NIVO) alone or in combination with ipilimumab (IPI) versus placebo in stage IV melanoma patients with no evidence of disease (NED): A randomized, double-blind phase 2 trial (IMMUNED)
Presenter: Dirk Schadendorf
Session: Proffered Paper – Melanoma and other skin tumours
Resources:
Abstract